| EMET | URA | EMET / URA | |
| Gain YTD | 25.297 | 7.817 | 324% |
| Net Assets | 39.2M | 6.42B | 1% |
| Total Expense Ratio | 0.62 | 0.69 | 90% |
| Turnover | 21.00 | 14.51 | 145% |
| Yield | 1.75 | 5.30 | 33% |
| Fund Existence | 5 years | 16 years | - |
| EMET | URA | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 81% | 4 days ago 90% |
| Stochastic ODDS (%) | 3 days ago 85% | 3 days ago 90% |
| Momentum ODDS (%) | 3 days ago 89% | 3 days ago 87% |
| MACD ODDS (%) | 3 days ago 85% | 3 days ago 90% |
| TrendWeek ODDS (%) | 3 days ago 87% | 3 days ago 90% |
| TrendMonth ODDS (%) | 3 days ago 84% | 3 days ago 90% |
| Advances ODDS (%) | 3 days ago 87% | 11 days ago 90% |
| Declines ODDS (%) | 26 days ago 87% | 26 days ago 90% |
| BollingerBands ODDS (%) | 3 days ago 84% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 88% | 3 days ago 90% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ETTY | 9.68 | 0.13 | +1.31% |
| Amplify Ethereum 3% Monthly Option Income ETF | |||
| PBE | 97.59 | 1.03 | +1.07% |
| Invesco Biotechnology & Genome ETF | |||
| SFLR | 38.83 | 0.13 | +0.33% |
| Innovator Equity Managed Floor ETF | |||
| PBSE | 31.26 | -0.01 | -0.03% |
| PGIM S&P 500 Buffer 20 ETF - Sep | |||
| IBIF | 25.77 | -0.04 | -0.14% |
| iShares iBonds Oct 2029 Term Tips ETF | |||
A.I.dvisor tells us that EMET and VAL have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EMET and VAL's prices will move in lockstep.
| Ticker / NAME | Correlation To EMET | 1D Price Change % | ||
|---|---|---|---|---|
| EMET | 100% | +5.71% | ||
| VAL - EMET | 13% Poorly correlated | -1.39% | ||
| AAL - EMET | -6% Poorly correlated | +2.22% |
A.I.dvisor indicates that over the last year, URA has been closely correlated with SMR. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if URA jumps, then SMR could also see price increases.